Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohan Bareja

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Experimental Medicine|May 5, 2022
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancerRenuka Raman, Jacques A Villefranc, Timothy M Ullmann, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
JCO Precision Oncology|January 16, 2018
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical ModelsDavid J Pisapia, Steven Salvatore, Chantal Pauli, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
The Oncologist|July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma TestingWael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
NPJ Precision Oncology|May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, David C Wilkes, Rohan Bareja, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Experimental Medicine|May 5, 2022
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancerRenuka Raman, Jacques A Villefranc, Timothy M Ullmann, et al.
Nature Communications|November 4, 2020
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticityJoanna Cyrta, Anke Augspach, Maria Rosaria De Filippo, et al.
Nature Communications|June 21, 2018
Patient derived organoids to model rare prostate cancer phenotypesLoredana Puca, Rohan Bareja, Davide Prandi, et al.
JCO Precision Oncology|January 16, 2018
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical ModelsDavid J Pisapia, Steven Salvatore, Chantal Pauli, et al.
Science (New York, N.Y.)|May 26, 2022
Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targetsFanying Tang, Duo Xu, Shangqian Wang, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Genomic alterations in the YAP/TAZ pathway are associated with stem cell-like castration-resistant prostate cancerMarjorie L Roskes, Alexander Martinez-Fundichely, Sandra Cohen, et al.
Nature Communications|November 5, 2021
Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancerMeixia Che, Aashi Chaturvedi, Sarah A Munro, et al.
The Oncologist|July 21, 2021
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma TestingWael Al Zoughbi, Jesse Fox, Shaham Beg, et al.
NPJ Precision Oncology|May 27, 2021
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemiaMayumi Sugita, David C Wilkes, Rohan Bareja, et al.
Cancer Discovery|December 29, 2020
Metastasis and Immune Evasion from Extracellular cGAMP HydrolysisJun Li, Mercedes A Duran, Ninjit Dhanota, et al.
Pageof 7